Skip to content

Journal · Biotechnology · Updated 21 November 2026

3 Biotech

Read 3 Biotech articles on DeepDyve. No university library needed.

3 Biotech has published since 2011 and covers applied biotechnology, from crop stress tolerance and gene delivery vectors to nanoparticles for food coatings and brain cancer treatment. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of 3 Biotech
Journal cover

3 Biotech at a glance

Full title
3 Biotech
Abbreviation (NLM)
3 Biotech
Publisher
Springer Nature
Print ISSN
2190-572X
Online ISSN (eISSN)
2190-5738
First published
2011
Access model
Hybrid (9% free to read in 2026)

Ways to access 3 Biotech

9% of the articles 3 Biotech published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 9% of 3 Biotech articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to 3 Biotech. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read 3 Biotech articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

3 Biotech’s 2025 Journal Impact Factor is 3.1, and its 5-year Impact Factor is 3.4.

3.1

Journal Impact Factor (2025)

3.4

5-year Impact Factor (2025)

30 days

Median time to first decision

1.6M

Downloads (2025)

Source: journal metrics on the 3 Biotech homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent 3 Biotech research worth reading

Published January to March 2026. Summaries describe what the authors report.

  1. LitStreamNeuroscience · Aging

    Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging

    Goel and colleagues review how changes in synaptic plasticity contribute to cognitive decline with age, and weigh drug, natural-compound and lifestyle approaches to restoring it, noting translational challenges such as limited clinical efficacy and a lack of personalized biomarkers.

    Goel et al. · 3 Biotech, published online January 5, 2026 · DOI 10.1007/s13205-025-04673-z

  2. LitStreamGlioblastoma · Natural products

    Mitochondria-mediated pyroptosis: anti-glioblastoma mechanism of the frankincense-derived compound β-boswellic acid

    Tang and colleagues report that β-boswellic acid, a compound from frankincense, inhibited glioblastoma cell growth and invasion in a dose-dependent manner and reduced tumor growth in mice, by damaging mitochondria and triggering NLRP3-mediated pyroptosis.

    Tang et al. · 3 Biotech, published online January 14, 2026 · DOI 10.1007/s13205-025-04691-x

  3. LitStreamNeurodegeneration · Natural products

    Bridging pathway dysfunction and therapy: novel compounds for neuroprotection

    Patel and colleagues review how natural compounds such as genistein, curcumin and luteolin act on signaling pathways disrupted in Alzheimer’s and Parkinson’s disease in laboratory studies, while noting low bioavailability and limited translational success.

    Patel et al. · 3 Biotech, published online January 20, 2026 · DOI 10.1007/s13205-026-04697-z

  4. LitStreamGut microbiota · Diarrhea

    Novel insights into diarrhea mechanism from gut-kidney axis perspective: correlations among intestinal mucosal injury, AQP4 water transport disorder and gut microbiota dysbiosis

    In a mouse model of kidney-yang deficiency diarrhea, Peng and colleagues report that gut microbiota dysbiosis damaged the colonic mucosa, raised inflammatory markers and lowered ADH and AQP4 expression, disrupting water metabolism through the gut-kidney axis.

    Peng et al. · 3 Biotech, published online March 25, 2026 · DOI 10.1007/s13205-026-04774-3

  5. Open accessPlant stress · Genome editing

    Modern plant stress adaptation: integrating defense, nanotechnology and genetics

    The authors review how plants adapt to biotic and abiotic stress and argue that combining CRISPR/Cas genome editing and nanomaterials with traditional agriculture may enhance plant resilience, sustain crop productivity and reduce reliance on chemical inputs.

    Meenakshi et al. · 3 Biotech, published online February 20, 2026 · DOI 10.1007/s13205-026-04732-z

See every 3 Biotech article on DeepDyve

Questions about 3 Biotech

How can I read 3 Biotech articles without a subscription?

9% of 3 Biotech articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read 3 Biotech articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for 3 Biotech?

3 Biotech isn’t abbreviated: its NLM (PubMed) abbreviation is simply 3 Biotech.

What is the ISSN of 3 Biotech?

The print ISSN is 2190-572X and the online ISSN is 2190-5738.

What is the impact factor of 3 Biotech?

3 Biotech’s Journal Impact Factor is 3.1 (2025), and its 5-year Impact Factor is 3.4, according to Springer Nature’s published metrics.

Is 3 Biotech open access?

3 Biotech is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 41 of 462 3 Biotech articles (9%) carry a Creative Commons license, per Crossref.

3 Biotech articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading 3 Biotech today

One month free, then less than $2 a day. 3 Biotech, plus millions of articles from thousands of journals.

Start free month

Like this: